SK Chemicals' Alzheimer's dementia treatment patch has ranked fourth in global market share, earning a spot among world-class products.
SK Chemicals announced on November 18 that its self-developed 'Rivastigmine Patch' has been selected as a '2026 Current World-Class Product' by the Ministry of Trade, Industry and Energy and KOTRA. Among the 27 products selected this year, this is the only pharmaceutical. The world-class product designation is a system that identifies products with global competitiveness based on market share and export performance. Products that have the potential to secure competitiveness within seven years are classified separately as next-generation world-class products.
According to global pharmaceutical market research firm IQVIA, SK Chemicals' Rivastigmine Patch generated approximately $38.3 million (about 54.5 billion won) in sales worldwide last year, holding a 12% market share, ranking fourth globally. The export declaration amount for the same year was approximately $14.35 million (about 20.4 billion won), the highest among domestic manufacturers of similar products.
The Rivastigmine Patch is applied to the skin once a day, allowing for a steady delivery of medication. The active ingredient, Rivastigmine, prevents the breakdown of acetylcholine, a neurotransmitter involved in memory and learning. This feature enhances convenience for dementia patients who have difficulty swallowing pills or managing medication schedules.
The product utilizes SK Chemicals' transdermal drug delivery system (TDS) technology. The company began development in 2007, building on technology accumulated from its arthritis treatment patch 'Trast' developed in the 1990s. After about five years of formulation development and equivalence testing, it received approval as the first generic Rivastigmine patch in Europe. Since then, it has expanded its sales regions to Latin America and the Middle East, and in 2019, it gained approval from the U.S. Food and Drug Administration (FDA) to enter the U.S. market.
Park Hyun-sun, head of SK Chemicals' pharmaceutical business, stated, "Formulation technology diversifies the forms of medication and is directly linked to improving patient convenience," adding, "We will provide diverse and useful treatment options through continuous research and development."
Meanwhile, SK Chemicals announced that it has signed a memorandum of understanding (MOU) with Seogwipo City to chemically recycle discarded banners into banner and textile products.
This agreement was initiated following SK Chemicals' proposal for a circular economy project involving discarded banners, which was selected as an excellent team during the 'Community Problem-Solving Idea Solverthon' hosted by the Ministry of the Interior and Safety and the Korea Chamber of Commerce and Industry in September.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.